F6Publishing

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Articles Published Processes

Keyword: Fatty liver

Page 1 of 2 ( 88 items )
<<
1
2
>>

1	Metabolic dysfunction-associated steatotic liver disease and type 2 diabetes: Pathophysiology, diagnosis, and emerging therapeutic strategies 2/6/2026 8:43:37 AM \| Browse: 112 \| Download: 369
2	Phase III, multicenter, randomized, double-blind, placebo-controlled study of norursodeoxycholic acid in metabolic dysfunction-associated steatotic liver disease patients 12/26/2025 10:27:34 AM \| Browse: 324 \| Download: 612
3	Targeting gut microbiota in liver disease: A pharmacological approach for hepatic encephalopathy and beyond 12/5/2025 11:28:03 AM \| Browse: 154 \| Download: 432
4	Quick glance at 'metabolic dysfunction associated steatotic liver disease' therapeutics: Targets, trials, and trends 12/5/2025 11:28:02 AM \| Browse: 163 \| Download: 376
5	Redefining fatty liver as metabolic dysfunction-associated steatotic liver disease: Implications of nomenclature changes for patients with diabetes 11/27/2025 7:54:00 AM \| Browse: 138 \| Download: 399
6	Is higher body mass index correlated with worse clinical outcomes in acute liver failure? 11/12/2025 9:50:40 AM \| Browse: 215 \| Download: 429
7	Risk factors analysis for poor prognosis after percutaneous drainage in liver abscess patients with fatty liver 10/24/2025 7:36:24 AM \| Browse: 237 \| Download: 525
8	Myths and facts about the role of diet in metabolic dysfunctionassociated steatotic liver disease 8/27/2025 9:21:10 AM \| Browse: 220 \| Download: 730
9	Liver function improvement after human placental extract injections in patients with chronic liver disease: Thirty case reports 6/4/2025 7:41:49 AM \| Browse: 135 \| Download: 718
10	High metabolic dysfunction-associated steatotic liver disease prevalence in type 2 diabetes: Urgent need for integrated screening and lifestyle intervention 1/6/2025 8:47:58 AM \| Browse: 250 \| Download: 746
11	Effect of alpha-lipoic acid and Silybum marianum supplementation with a Mediterranean diet on metabolic dysfunction-associated steatosis 1/6/2025 8:47:56 AM \| Browse: 235 \| Download: 874
12	Predicting colorectal adenomatous polyps in patients with chronic liver disease: A novel nomogram 12/18/2024 7:36:04 AM \| Browse: 176 \| Download: 803
13	Metabolic dysfunction-associated steatotic liver disease: A silent pandemic 4/24/2024 8:35:39 AM \| Browse: 184 \| Download: 764
14	Protein succinylation, hepatic metabolism, and liver diseases 3/27/2024 1:28:19 PM \| Browse: 192 \| Download: 738
15	Establishment and validation of an adherence prediction system for lifestyle interventions in non-alcoholic fatty liver disease 3/14/2024 5:31:16 PM \| Browse: 477 \| Download: 1790
16	Efficacy and safety of semaglutide in non-alcoholic fatty liver disease 9/25/2023 9:07:43 AM \| Browse: 473 \| Download: 1598
17	Advances in application of novel magnetic resonance imaging technologies in liver disease diagnosis 7/26/2023 11:55:37 AM \| Browse: 469 \| Download: 1170
18	Insulin resistance and adipose tissue interactions as the cornerstone of metabolic (dysfunction)-associated fatty liver disease pathogenesis 6/28/2023 7:41:03 AM \| Browse: 452 \| Download: 1136
19	Association of non-alcoholic fatty liver and metabolic-associated fatty liver with COVID-19 outcomes: A systematic review and meta-analysis 6/1/2023 1:04:32 PM \| Browse: 464 \| Download: 1178
20	Fatty liver and celiac disease: Why worry? 5/24/2023 9:31:05 AM \| Browse: 512 \| Download: 1320
21	Diabetes and fatty liver: Involvement of incretin and its benefit for fatty liver management 5/15/2023 3:23:22 PM \| Browse: 513 \| Download: 1380
22	Liver involvement in patients with COVID-19 infection: A comprehensive overview of diagnostic imaging features 2/6/2023 12:22:17 PM \| Browse: 722 \| Download: 1268
23	Non-alcoholic fatty liver disease and COVID-19: Harmless companions or disease intensifier? 1/6/2023 2:52:58 AM \| Browse: 527 \| Download: 1024
24	In vivo recognition of bioactive substances of Polygonum multiflorum for protecting mitochondria against metabolic dysfunction-associated fatty liver disease 1/4/2023 5:53:02 AM \| Browse: 624 \| Download: 1638
25	Combination strategies for pharmacologic treatment of non-alcoholic steatohepatitis 9/15/2022 1:37:25 PM \| Browse: 772 \| Download: 1557
26	How to select the quantitative magnetic resonance technique for subjects with fatty liver: A systematic review 8/26/2022 9:54:52 AM \| Browse: 607 \| Download: 1688
27	Higher cardiovascular risk scores and liver fibrosis risk estimated by biomarkers in patients with metabolic-dysfunction-associated fatty liver disease 8/26/2022 9:51:35 AM \| Browse: 872 \| Download: 1668
28	Factors early in life associated with hepatic steatosis 6/23/2022 2:39:01 PM \| Browse: 778 \| Download: 1878
29	Application of artificial intelligence in non-alcoholic fatty liver disease and viral hepatitis 4/29/2022 11:12:04 AM \| Browse: 833 \| Download: 1617
30	Promising diagnostic biomarkers of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: From clinical proteomics to microbiome 11/24/2021 9:54:22 AM \| Browse: 994 \| Download: 2104
31	Machine learning models for predicting non-alcoholic fatty liver disease in the general United States population: NHANES database 10/22/2021 1:53:28 PM \| Browse: 801 \| Download: 2164
32	Standard liver weight model in adult deceased donors with fatty liver: A prospective cohort study. 10/20/2021 7:18:39 AM \| Browse: 813 \| Download: 1879
33	Impact of COVID-19 on liver 9/16/2021 8:48:21 AM \| Browse: 896 \| Download: 1397
34	Association of non-alcoholic fatty liver disease and COVID-19: A literature review of current evidence 8/20/2021 9:33:19 AM \| Browse: 1022 \| Download: 2232
35	Prevalence and risk factors of steatosis and advanced fibrosis using transient elastography in the United States’ adolescent population 7/23/2021 8:10:13 AM \| Browse: 983 \| Download: 2089
36	Non-alcoholic fatty liver disease and COVID-19: An epidemic that begets pandemic 5/26/2021 9:58:01 AM \| Browse: 798 \| Download: 1706
37	Metabolic complications of hepatitis C virus infection 3/30/2021 7:03:44 AM \| Browse: 1085 \| Download: 1870
38	Effects of proprotein convertase subtilisin/kexin type-9 inhibitors on fatty liver 12/18/2020 5:58:43 AM \| Browse: 1062 \| Download: 2541
39	Metabolic associated fatty liver disease: Addressing a new era in liver transplantation 12/18/2020 5:58:43 AM \| Browse: 1159 \| Download: 1858
40	Fatty liver is an independent risk factor for gallbladder polyps 11/27/2020 9:27:48 AM \| Browse: 1251 \| Download: 2756
41	Cannabis use history is associated with increased prevalence of ascites among patients with nonalcoholic fatty liver disease: A nationwide analysis 11/24/2020 12:41:21 PM \| Browse: 989 \| Download: 2736
42	Relationship between non-alcoholic fatty liver disease and coronary heart disease 10/26/2020 9:59:39 AM \| Browse: 1038 \| Download: 2000
43	Can gadoxetic acid–enhanced magnetic resonance imaging be used to avoid liver biopsy in patients with nonalcoholic fatty liver disease? 9/21/2020 4:02:08 PM \| Browse: 963 \| Download: 2829
44	Glucagon-like peptide-1 receptor agonists in non-alcoholic fatty liver disease: An update 8/25/2020 9:16:00 AM \| Browse: 1028 \| Download: 2543
45	Medications in type-2 diabetics and their association with liver fibrosis 6/21/2020 2:15:44 PM \| Browse: 1052 \| Download: 2088
46	Non-alcoholic fatty liver disease and Atherosclerosis at a crossroad: The overlap of a theory of change and bioinformatics 5/12/2020 3:08:42 AM \| Browse: 1179 \| Download: 1962
47	Comparison of four non-alcoholic fatty liver disease detection scores in a Caucasian population 4/23/2020 10:34:55 AM \| Browse: 1135 \| Download: 2486
48	Single strain probiotics for dyslipidemia, fatty liver, and obesity: A systematic review and meta-analysis 6/30/2019 3:51:24 AM \| Browse: 1629 \| Download: 3010
49	C-peptide as a key risk factor for non-alcoholic fatty liver disease in the United States population 8/27/2018 7:22:43 AM \| Browse: 1379 \| Download: 2449
50	Liver intravoxel incoherent motion diffusion-weighted imaging for the assessment of hepatic steatosis and fibrosis in children 7/19/2018 7:04:34 AM \| Browse: 1502 \| Download: 3081

Page 1 of 2 ( 88 items )
<<
1
2
>>

1	Metabolic dysfunction-associated steatotic liver disease and type 2 diabetes: Pathophysiology, diagnosis, and emerging therapeutic strategies 2/6/2026 8:43:37 AM \| Browse: 112 \| Download: 369
2	Phase III, multicenter, randomized, double-blind, placebo-controlled study of norursodeoxycholic acid in metabolic dysfunction-associated steatotic liver disease patients 12/26/2025 10:27:34 AM \| Browse: 324 \| Download: 612
3	Targeting gut microbiota in liver disease: A pharmacological approach for hepatic encephalopathy and beyond 12/5/2025 11:28:03 AM \| Browse: 154 \| Download: 432
4	Quick glance at 'metabolic dysfunction associated steatotic liver disease' therapeutics: Targets, trials, and trends 12/5/2025 11:28:02 AM \| Browse: 163 \| Download: 376
5	Redefining fatty liver as metabolic dysfunction-associated steatotic liver disease: Implications of nomenclature changes for patients with diabetes 11/27/2025 7:54:00 AM \| Browse: 138 \| Download: 399
6	Is higher body mass index correlated with worse clinical outcomes in acute liver failure? 11/12/2025 9:50:40 AM \| Browse: 215 \| Download: 429
7	Risk factors analysis for poor prognosis after percutaneous drainage in liver abscess patients with fatty liver 10/24/2025 7:36:24 AM \| Browse: 237 \| Download: 525
8	Myths and facts about the role of diet in metabolic dysfunctionassociated steatotic liver disease 8/27/2025 9:21:10 AM \| Browse: 220 \| Download: 730
9	Liver function improvement after human placental extract injections in patients with chronic liver disease: Thirty case reports 6/4/2025 7:41:49 AM \| Browse: 135 \| Download: 718
10	High metabolic dysfunction-associated steatotic liver disease prevalence in type 2 diabetes: Urgent need for integrated screening and lifestyle intervention 1/6/2025 8:47:58 AM \| Browse: 250 \| Download: 746
11	Effect of alpha-lipoic acid and Silybum marianum supplementation with a Mediterranean diet on metabolic dysfunction-associated steatosis 1/6/2025 8:47:56 AM \| Browse: 235 \| Download: 874
12	Predicting colorectal adenomatous polyps in patients with chronic liver disease: A novel nomogram 12/18/2024 7:36:04 AM \| Browse: 176 \| Download: 803
13	Metabolic dysfunction-associated steatotic liver disease: A silent pandemic 4/24/2024 8:35:39 AM \| Browse: 184 \| Download: 764
14	Protein succinylation, hepatic metabolism, and liver diseases 3/27/2024 1:28:19 PM \| Browse: 192 \| Download: 738
15	Establishment and validation of an adherence prediction system for lifestyle interventions in non-alcoholic fatty liver disease 3/14/2024 5:31:16 PM \| Browse: 477 \| Download: 1790
16	Efficacy and safety of semaglutide in non-alcoholic fatty liver disease 9/25/2023 9:07:43 AM \| Browse: 473 \| Download: 1598
17	Advances in application of novel magnetic resonance imaging technologies in liver disease diagnosis 7/26/2023 11:55:37 AM \| Browse: 469 \| Download: 1170
18	Insulin resistance and adipose tissue interactions as the cornerstone of metabolic (dysfunction)-associated fatty liver disease pathogenesis 6/28/2023 7:41:03 AM \| Browse: 452 \| Download: 1136
19	Association of non-alcoholic fatty liver and metabolic-associated fatty liver with COVID-19 outcomes: A systematic review and meta-analysis 6/1/2023 1:04:32 PM \| Browse: 464 \| Download: 1178
20	Fatty liver and celiac disease: Why worry? 5/24/2023 9:31:05 AM \| Browse: 512 \| Download: 1320
21	Diabetes and fatty liver: Involvement of incretin and its benefit for fatty liver management 5/15/2023 3:23:22 PM \| Browse: 513 \| Download: 1380
22	Liver involvement in patients with COVID-19 infection: A comprehensive overview of diagnostic imaging features 2/6/2023 12:22:17 PM \| Browse: 722 \| Download: 1268
23	Non-alcoholic fatty liver disease and COVID-19: Harmless companions or disease intensifier? 1/6/2023 2:52:58 AM \| Browse: 527 \| Download: 1024
24	In vivo recognition of bioactive substances of Polygonum multiflorum for protecting mitochondria against metabolic dysfunction-associated fatty liver disease 1/4/2023 5:53:02 AM \| Browse: 624 \| Download: 1638
25	Combination strategies for pharmacologic treatment of non-alcoholic steatohepatitis 9/15/2022 1:37:25 PM \| Browse: 772 \| Download: 1557
26	How to select the quantitative magnetic resonance technique for subjects with fatty liver: A systematic review 8/26/2022 9:54:52 AM \| Browse: 607 \| Download: 1688
27	Higher cardiovascular risk scores and liver fibrosis risk estimated by biomarkers in patients with metabolic-dysfunction-associated fatty liver disease 8/26/2022 9:51:35 AM \| Browse: 872 \| Download: 1668
28	Factors early in life associated with hepatic steatosis 6/23/2022 2:39:01 PM \| Browse: 778 \| Download: 1878
29	Application of artificial intelligence in non-alcoholic fatty liver disease and viral hepatitis 4/29/2022 11:12:04 AM \| Browse: 833 \| Download: 1617
30	Promising diagnostic biomarkers of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: From clinical proteomics to microbiome 11/24/2021 9:54:22 AM \| Browse: 994 \| Download: 2104
31	Machine learning models for predicting non-alcoholic fatty liver disease in the general United States population: NHANES database 10/22/2021 1:53:28 PM \| Browse: 801 \| Download: 2164
32	Standard liver weight model in adult deceased donors with fatty liver: A prospective cohort study. 10/20/2021 7:18:39 AM \| Browse: 813 \| Download: 1879
33	Impact of COVID-19 on liver 9/16/2021 8:48:21 AM \| Browse: 896 \| Download: 1397
34	Association of non-alcoholic fatty liver disease and COVID-19: A literature review of current evidence 8/20/2021 9:33:19 AM \| Browse: 1022 \| Download: 2232
35	Prevalence and risk factors of steatosis and advanced fibrosis using transient elastography in the United States’ adolescent population 7/23/2021 8:10:13 AM \| Browse: 983 \| Download: 2089
36	Non-alcoholic fatty liver disease and COVID-19: An epidemic that begets pandemic 5/26/2021 9:58:01 AM \| Browse: 798 \| Download: 1706
37	Metabolic complications of hepatitis C virus infection 3/30/2021 7:03:44 AM \| Browse: 1085 \| Download: 1870
38	Effects of proprotein convertase subtilisin/kexin type-9 inhibitors on fatty liver 12/18/2020 5:58:43 AM \| Browse: 1062 \| Download: 2541
39	Metabolic associated fatty liver disease: Addressing a new era in liver transplantation 12/18/2020 5:58:43 AM \| Browse: 1159 \| Download: 1858
40	Fatty liver is an independent risk factor for gallbladder polyps 11/27/2020 9:27:48 AM \| Browse: 1251 \| Download: 2756
41	Cannabis use history is associated with increased prevalence of ascites among patients with nonalcoholic fatty liver disease: A nationwide analysis 11/24/2020 12:41:21 PM \| Browse: 989 \| Download: 2736
42	Relationship between non-alcoholic fatty liver disease and coronary heart disease 10/26/2020 9:59:39 AM \| Browse: 1038 \| Download: 2000
43	Can gadoxetic acid–enhanced magnetic resonance imaging be used to avoid liver biopsy in patients with nonalcoholic fatty liver disease? 9/21/2020 4:02:08 PM \| Browse: 963 \| Download: 2829
44	Glucagon-like peptide-1 receptor agonists in non-alcoholic fatty liver disease: An update 8/25/2020 9:16:00 AM \| Browse: 1028 \| Download: 2543
45	Medications in type-2 diabetics and their association with liver fibrosis 6/21/2020 2:15:44 PM \| Browse: 1052 \| Download: 2088
46	Non-alcoholic fatty liver disease and Atherosclerosis at a crossroad: The overlap of a theory of change and bioinformatics 5/12/2020 3:08:42 AM \| Browse: 1179 \| Download: 1962
47	Comparison of four non-alcoholic fatty liver disease detection scores in a Caucasian population 4/23/2020 10:34:55 AM \| Browse: 1135 \| Download: 2486
48	Single strain probiotics for dyslipidemia, fatty liver, and obesity: A systematic review and meta-analysis 6/30/2019 3:51:24 AM \| Browse: 1629 \| Download: 3010
49	C-peptide as a key risk factor for non-alcoholic fatty liver disease in the United States population 8/27/2018 7:22:43 AM \| Browse: 1379 \| Download: 2449
50	Liver intravoxel incoherent motion diffusion-weighted imaging for the assessment of hepatic steatosis and fibrosis in children 7/19/2018 7:04:34 AM \| Browse: 1502 \| Download: 3081